+1 310 883 6493 rjantz@cooley.com
Rick Jantz focuses on domestic and international transactional tax matters. He has advised public and private companies, private equity funds, financial institutions and non-profit organizations.
Download full bio
X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics
GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals
Vir Biotechnology - $143 Million IPO
Arlo to Partner with Verisure
Reata Pharmaceuticals – $505 Million Follow-On Offering
View all
Tax
Mergers & Acquisitions
Private Equity
New York University School of LawJD, Jacobson Scholar, 2015
University of California, Los AngelesBA, Business Economics2012
California
Super Group to Combine With SPAC Sports Entertainment Acquisition Corp April 25, 2021
IonQ Agrees to SPAC Merger With dMY Technology Group III March 19, 2021
Brandwatch Agrees to Sell to Cision for $450 Million March 15, 2021
+1 310 883 6493 office rjantz@cooley.com
1333 2nd StreetSuite 400Santa Monica, CA 90401